General Info
Novo Nordisk is a healthcare company that produces and distributes insulin and other diabetes drugs to treat chronic diseases.
Location: Bagsværd
Country:
Industries:
Investment Regions: EU
Investment Stages: late-stage
Website: https://www.novonordisk.com/
corporate-vc
EU
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: not-active
AI Reasoning: Search of Novo Nordisk news and press releases found a recent acquisition proposal: Novo Nordisk submitted a proposal to acquire Metsera, Inc. The news shows activity in 2025, but the last identifiable investment/transaction specifically as an investor in a startup (Metsera) occurred in September 2024 according to the press release timeline available on Novo Nordisk’s site. That investment/transaction therefore happened more than 12 months prior to the required evaluation date, indicating the investor has not made investments within the past 12 months.
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Warm Intros from Portfolio Companies
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Novo Nordisk
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI